Agena Biosciences is advancing rapid and accurate genetic testing solutions including viral RNA detection of COVID-19. While sequencing-based technologies are commonly used in diagnostics, they are highly complex, expensive and have a long turnaround time. Agena has instead developed a suite of MassARRAY panels that enable accurate, high-throughput, and low cost detection of viruses such as SARS-CoV-2. Agena also provides Custom Assay services to design, develop and functionally verify assays for germline or somatic genotyping, translocations, copy number variants and methylation profiling. With these tools, Agena helps laboratories translate genomic discoveries into targeted, cost-effective testing.
Claim company profile to post jobs directly on this page and this website.